BSE Live
Nov 07, 16:01Prev. Close
134.70
Open Price
134.70
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 07, 15:55Prev. Close
134.58
Open Price
134.02
Bid Price (Qty.)
133.35 (886)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Sun Pharma Advanced Research Company (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | |
| Per Share Ratios | ||||
| Basic EPS (Rs.) | -10.55 | -11.93 | -7.82 | |
| Diluted EPS (Rs.) | -10.55 | -11.93 | -7.82 | |
| Cash EPS (Rs.) | -10.17 | -11.55 | -6.50 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | -6.68 | 3.88 | 15.80 | |
| Book Value [InclRevalReserve]/Share (Rs.) | -6.68 | 3.88 | 15.80 | |
| Revenue from Operations/Share (Rs.) | 2.21 | 2.33 | 7.36 | |
| PBDIT/Share (Rs.) | -9.90 | -11.48 | -6.26 | |
| PBIT/Share (Rs.) | -10.28 | -11.87 | -6.62 | |
| PBT/Share (Rs.) | -10.56 | -11.92 | -6.86 | |
| Net Profit/Share (Rs.) | -10.55 | -11.93 | -6.86 | |
| NP After MI And SOA / Share (Rs.) | -10.55 | -11.93 | -6.86 | |
| Profitability Ratios | ||||
| PBDIT Margin (%) | -447.77 | -493.24 | -85.09 | |
| PBIT Margin (%) | -465.04 | -509.80 | -90.01 | |
| PBT Margin (%) | -477.63 | -512.05 | -93.21 | |
| Net Profit Margin (%) | -477.25 | -512.55 | -93.21 | |
| NP After MI And SOA Margin (%) | -477.25 | -512.55 | -93.21 | |
| Return on Networth/Equity (%) | 0.00 | -307.91 | -43.40 | |
| Return on Capital Employed (%) | 862.23 | -154.06 | -33.00 | |
| Return on Assets (%) | -102.07 | -75.18 | -26.81 | |
| Total Debt/Equity (X) | -1.19 | 0.37 | 0.00 | |
| Asset Turnover Ratio (%) | 0.17 | 0.11 | 0.00 | |
| Liquidity Ratios | ||||
| Current Ratio (X) | 0.07 | 1.02 | 2.54 | |
| Quick Ratio (X) | 0.07 | 1.02 | 2.54 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||
| Interest Coverage Ratios (%) | -35.55 | -219.89 | -26.61 | |
| Interest Coverage Ratios (Post Tax) (%) | -35.55 | -219.89 | -26.61 | |
| Valuation Ratios | ||||
| Enterprise Value (Cr.) | 5,059.27 | 11,897.66 | 5,712.17 | |
| EV/Net Operating Revenue (X) | 70.50 | 157.49 | 23.92 | |
| EV/EBITDA (X) | -15.74 | -31.93 | -28.11 | |
| MarketCap/Net Operating Revenue (X) | 66.93 | 158.92 | 24.39 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | -22.14 | 95.47 | 11.36 | |
| Price/Net Operating Revenue | 66.93 | 158.93 | 24.39 | |
| Earnings Yield | -0.07 | -0.03 | -0.04 |
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
20.05.2025
Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
20.05.2025
Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
20.05.2025
Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
20.05.2025
Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y